申请人:Rhone-Poulenc Rorer Pharmaceuticals Inc.
公开号:US05001144A1
公开(公告)日:1991-03-19
Disclosed are novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula ##STR1## and the corresponding ring-opened hydroxy acids derived therefrom and pharmaceutically acceptable salts thereof. Phamaceutical compositions containing said compounds and method of inhibiting the biosynthesis of cholesterol therewith are also disclosed.
揭示了作为抗高胆固醇药物有用的新型3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂,其化学式为##STR1##以及相应的开环羟基酸及其药用可接受盐。还揭示了含有这些化合物的药物组合物以及利用它们抑制胆固醇生物合成的方法。